Vulnerability in Eprosima Fast Dds
CVE-2021-38425
eProsima Fast DDS versions prior to 2.4.0 (#2269) are susceptible to exploitation when an attacker sends a specially crafted packet to flood a target device with unwanted traffic, which may result in a denial-of-service condition and information exposure.
Published · last modified .
CVSS v3 metric
CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:N/A:H.
EPSS exploit prediction
EPSS: 0.051 (92.3th percentile), scored .
Low probability of exploitation in the next 30 days, but still tracked. 92nd percentile — 92.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.051 · newest: 0.051 · change: +0.000
Affected products
- Eprosima Fast Dds — versions unspecified
- Eprosima Fast Dds
Weakness classification (CWE)
References
- www.cisa.gov/uscert/ics/advisories/icsa-21-315-02 (US Government Resource, Third Party Advisory)
- github.com/eProsima/Fast-DDS (Product, Third Party Advisory)
Frequently asked questions
- What is CVE-2021-38425?
- CVE-2021-38425 is a high-severity vulnerability in Eprosima Fast Dds, classified under CWE-406. CVSS score: 7.5/10. Published 2022-05-05.
- How severe is CVE-2021-38425?
- High severity. CVSS v3 base score is 7.5 out of 10.